Jeffrey Launay

MBiotech Alumnus

Director, Commercial Effectiveness at Purdue Pharma Canada
Class of 2005

A graduate from the M.Biotech program in 2005, Jeffrey completed his internship at Patheon Canada Market Research. He spent four years in a series of progressive positions at Patheon, including a rotation with Patheon UK based in London, England. Prior to leaving Patheon, Jeffrey was leading the Market Research group responsible for meeting the market research needs of the global organization.

After a rewarding experience at Patheon, Jeffrey was looking to move into a global pharmaceutical organization and was interested in a role in Pharmaceutical Sales. He started at GlaxoSmithKline Canada as a Territory Representative in 2007. His talents were quickly recognized at GSK and he was enrolled into the National Esprit Program, an accelerated leadership development program. Following his first role at GSK in sales, he worked in National Health Policy, Primary Care Marketing and Specialty Care and Oncology Marketing. He was recognized at GSK as a Regional Top Performer in Sales and received two GSK Spirit Awards in Marketing for entrepreneurship and innovation. In an effort to further develop his skills and knowledge, he completed a rotation with the US Oncology Marketing Team, based in Philadelphia, Pennsylvania. Jeffrey returned to Canada as a National Sales Manager, Oncology with GSK before moving to Novartis Oncology as an Associate Sales Director.

Jeffrey is currently Director, Commercial Effectiveness at Purdue Pharma Canada. he is leading a group responsible for all Commercial Operations at Purdue, including Sales Training, Market Research & Analysis, Commercial Compliance and Commercial Systems Administration & Reporting.  

The most valuable parts of M.Biotech for Jeffrey were learning how to work effectively in teams, and also how to take extremely complex ideas and distill them down to the most critical and actionable elements for the completion of a given project. These skills have served him exceptionally well during his career and will continue to do so as the global biopharmaceutical industry continues its rapid evolution, creating new and exciting opportunities for individuals with flexible thinking, an ability to drive change, and build relationships.